Our Pipeline
Teva Specialty Product Pipeline
Download PDF
Teva specialty pipeline by development stage, excluding country / regional launches of products submitted or under review in new markets.
* Visit https://www.tevausa.com/our-products/article-pages/Specialty-Medicines-List/ for full prescribing information for these products in the US.
Pipeline is current as of November 2019
[1] These uses are investigational. Fremanezumab is approved in the United States for another indication as AJOVY ® (fremanezumab-vfrm) injection*
[2] In partnership with Regeneron.
[3] These uses are investigational. Deutetrabenazine is approved in the United States for other indications as AUSTEDO® (deutetrabenazine) tablets*
